Pituitary tumours: all silent on the epigenetics front
Open Access
- 9 February 2009
- journal article
- review article
- Published by Bioscientifica in Journal of Molecular Endocrinology
- Vol. 42 (6) , 461-468
Abstract
Investigation of the epigenome of sporadic pituitary tumours is providing a more detailed understanding of aberrations that characterise this tumour type. Early studies, in this and other tumour types adopted candidate-gene approaches to characterise CpG island methylation as a mechanism responsible for or associated with gene silencing. However, more recently, investigators have adopted approaches that do not require a priori knowledge of the gene and transcript, as example differential display techniques, and also genome-wide, array-based approaches, to ‘uncover’ or ‘unmask’ silenced genes. Furthermore, through use of chromatin immunoprecipitation as a selective enrichment technique; we are now beginning to identify modifications that target the underlying histones themselves and that have roles in gene-silencing events. Collectively, these studies provided convincing evidence that change to the tumour epigenome are not simply epiphenomena but have functional consequences in the context of pituitary tumour evolution. Our ability to perform these types of studies has been and is increasingly reliant upon technological advances in the genomics and epigenomics arena. In this context, other more recent advances and developing technologies, and, in particular, next generation or flow cell re-sequencing techniques offer exciting opportunities for our future studies of this tumour type.Keywords
This publication has 18 references indexed in Scilit:
- Genome-Wide Analysis in a Murine Dnmt1 Knockdown Model Identifies Epigenetically Silenced Genes in Primary Human Pituitary TumorsMolecular Cancer Research, 2008
- Epigenetic gene silencing in cancer: the DNA hypermethylomeHuman Molecular Genetics, 2007
- Genome-Wide Analysis of Epigenetic Silencing Identifies BEX1 and BEX2 as Candidate Tumor Suppressor Genes in Malignant GliomaCancer Research, 2006
- Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cellsNature Genetics, 2005
- Hypermethylation of the Promoter Region Is Associated with the Loss ofMEG3Gene Expression in Human Pituitary TumorsThe Journal of Clinical Endocrinology & Metabolism, 2005
- Molecular targets in pituitary tumoursNature Reviews Cancer, 2004
- Molecular Pathology Shows p16 Methylation in Nonadenomatous Pituitaries from Patients with Cushing’s DiseaseClinical Cancer Research, 2004
- Mechanisms for pituitary tumorigenesis: the plastic pituitaryJournal of Clinical Investigation, 2003
- Loss of Expression ofGADD45γ, a Growth Inhibitory Gene, in Human Pituitary Adenomas: Implications for TumorigenesisThe Journal of Clinical Endocrinology & Metabolism, 2002
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987